Aptuit and GSK Extend Strategic Partnership

                 Aptuit and GSK Extend Strategic Partnership

  PR Newswire

  GREENWICH, Connecticut, Nov. 13, 2012

GREENWICH, Connecticut, Nov. 13, 2012 /PRNewswire/ --Aptuit LLC announced
that the company has reached an agreement on a multiyear extension of its
strategic partnership with GlaxoSmithKline (GSK) for dedicated drug
development work at The Aptuit Center for Drug Discovery & Development in
Verona, Italy. The Verona site – formerly known as GSK's Medicines Research
Centre – was acquired by Aptuit from GSK in 2010.

(Logo: http://photos.prnewswire.com/prnh/20120217/NY55633LOGO )

Timothy C. Tyson, Chairman, Aptuit LLC said, "This multiyear extension of our
partnership with GSK reaffirms that our Verona site continues to deliver
scientific excellence that is recognized by our customers. Since we finalized
our original agreement with GSK in 2010, we have successfully transformed the
Verona site from a pharmaceutical research center to a world-class drug
discovery and development outsourcing capability."

Mr. Tyson explained that during the two years since the Verona site became
part of Aptuit it has effectively transitioned to a lean, flexible,
customer-focused pharmaceutical services operation. To date, the Verona site
has had approximately 50 successful audits and has delivered work for more
than 90 clients. Mr. Tyson added, "Aptuit initiatives in Verona, such as Lean
Six Sigma, are resulting in productivity benefits across our business lines.
The high level of quality and regulatory compliance demonstrated in our work
has been noticeable to the more than 200 customers who have visited the site
since 2010."

For additional press information or to arrange an interview, please contact
Maria Garvey by phone at 914-747-1400 or send an email to maria@delfino.com .

Aptuit LLC provides the most complete set of integrated early to mid-phase
development services in the pharmaceutical industry. Drug Design & Discovery,
Preclinical Biosciences, API Development and Manufacture, Solid State
Chemistry, Drug Product Formulation Development & Manufacture, Sterile Fill
Finish, Clinical Sciences, Consulting and Aptuit INDiGO® (a program that
accelerates drug development) are offered as stand alone or integrated
services. Fully integrated drug discovery & development services are available
from a single site at The Aptuit Center for Drug Discovery & Development in
Verona, Italy. The company maintains five global facilities with approximately
800 employees in Europe and the United States, and has a strategic
relationship with Laurus Labs in India. Aptuit LLC is partnered with Welsh,
Carson, Anderson & Stowe, one of the world's leading private equity investors.

For more information about Aptuit, visit www.aptuit.com

Website: http://www.aptuit.com